Mechanism for invasion of tumorous cells discovered by Hebrew University researchers

	Tweet

Researchers at the Hebrew University of Jerusalem have discovered a previously unknown mechanism whereby tumor cells invade normal tissues, spreading cancer through various organs.

The ability of tumor cells to invade adjacent structures is a prerequisite for metastasis and distinguishes malignant tumors from benign ones. Thus, understanding the mechanisms that drive malignant cells to invade and a possible avenue for halting that mechanism could have tremendous potential for enhancing early detection of malignant cells and for therapeutic treatment.

It has previously been assumed that tumor cells turn invasive upon accumulation of multiple mutations, each giving the cancer cell some invasive properties

Now, Prof. Yinon Ben-Neriah and Dr. Eli Pikarsky of the Institute for Medical Research Israel-Canada at the Hebrew University Faculty of Medicine and their colleagues are reporting an alternative mechanism through which tumor cells become invasive. They found a program that is operated by a concerted group of genes that, when activated together, confer invasive properties upon epithelial cells. (Epithelial tissues line the cavities and surfaces of structures throughout the body, and also form many glands.) An article reporting their work appeared in a recent issue of the journal Nature.

Interestingly, the expression of this entire gene group is normally suppressed by a single gene – p53 – that is considered as the most important tumor suppressor but unfortunately is inactivated in the majority of human cancers. Some key properties of the protein produced by the p53 gene—arresting cell growth and induction of cell death – were previously discovered by Dr. Moshe Oren of the Weizmann Institute of Science, another member of the current research team. These properties were thought to explain the main cancer protection activity of p53. However, the new research now described in Nature describes a different mechanism of action of p53—inhibition of cell invasion—which may be the most critical means of cancer-protection in colon and rectal cancers and possibly other types of epithelial cancers.

Two Hebrew University doctoral students on the investigative team, Ela Elyada and Ariel Pribluda, developed a new mouse model in which they were able to demonstrate a process of genetically induced invasiveness of tumorous tissue and how that process could be prevented as long as p53 could be kept activated.

The new study may have important implications for cancer diagnosis and therapy.

The discovery of new invasion-activating genes could serve as diagnostic biomarkers for distinguishing malignant from benign lesions and the early detection of invasive cancer. This distinction is a critical determinant of therapeutic options, a judgment based today solely on microscopic study of tissue slides. With the availability of a prompt and exact molecular definition of invasive versus non-invasive lesions, lives could be saved by allowing the early implementation of curative treatments while withholding patient overtreatment, which often results in serious morbidity.

The reported findings may also indicate new measures for ways to maintain activation of p53 as a safeguard against malignant transformation of epithelial tissues.

###

This study was primarily funded by research grants from the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation and the Israel Science Foundation.

###

Contact: Jerry Barach

972-258-82904
The Hebrew University of Jerusalem

RELATED STORIES:
Quality of life with cancer can be preserved   How What and How Much We Eat (And Drink) Affects Our Risk of Cancer   Simple test could cut cancer deaths in poor nations   End of life care for cancer patients differs in US and Canada   New Markers of Prognosis for Cancer Therapies Highlighted   Researchers Identify Role of Gene in Tumor Development   Exercise Can Reduce Side Effects of Cancer Treatment   Childhood Leukemia Survivors Struggle With Long-Term Comorbidities   Experts say 40 percent of cancers could be prevented   Medical costs of cancer have nearly doubled over the past 2 decades   Life after chemotherapy: Daily tasks, quality of life may be affected, MU researcher finds   Innovative method to starve tumors   Gene That Causes Childhood Cancer Neuroblastoma Is Found   Improving Cancer Diagnosis   University of the Basque Country team develop nano-hydrogels capable of detecting cancer cells   Cancer, genes and broccoli   Keeping at-risk cells from developing cancer   Women underrepresented in most cancer research   Medical Society’s Labor Day CheckList Addresses Cancer Prevention   Scientists Identify Cancer Virus’ Genetic Targets   Costly Cancer Treatments: No Easy Access in U.S. or U.K.   Punctuated evolution in cancer genomes

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]